Page last updated: 2024-08-21

benzoxazoles and Autosomal Dominant Juvenile Parkinson Disease

benzoxazoles has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	5 (71.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JW; Choo, H; Kim, Y; Lee, CJ; Min, SJ; Nam, MH; Park, H; Park, JH; Park, KD; Park, M; Sawant, VS; Yoon, S	1
Di Paolo, T; Grégoire, L; Lévesque, D; Morissette, M; Ouattara, B; Rouillard, C; Samadi, P; Tamim, MK	1
Bélanger, N; Di Paolo, T; Hadj Tahar, A; Morissette, M; Samadi, P	1
Bronzova, J; Hauser, RA; Lang, AE; Rascol, O; Sampaio, C; Theeuwes, A; van de Witte, SV; van Scharrenburg, G	1
Jackson, MJ; Jenner, PG; Johnston, LC; Jones, CA; McCreary, AC; Rose, S; Smith, LA; van Scharrenburg, G	1
Bédard, PJ; Calon, F; Di Paolo, T; Dridi, M; Hadj Tahar, A; Meltzer, LT; Morissette, M	1
Bédard, PJ; Belanger, N; Calon, F; Di Paolo, T; Dridi, M; Hadj Tahar, A; Meltzer, LT; Morissette, M; Samadi, P	1

Trials

1 trial(s) available for benzoxazoles and Autosomal Dominant Juvenile Parkinson Disease

Article	Year
Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Apr-30, Volume: 25, Issue:6 Topics: Aged; Benzoxazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Piperazines; Severity of Illness Index; Treatment Outcome	2010

Article

Year

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 2010, Apr-30, Volume: 25, Issue:6

Topics: Aged; Benzoxazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Piperazines; Severity of Illness Index; Treatment Outcome

2010

Other Studies

6 other study(ies) available for benzoxazoles and Autosomal Dominant Juvenile Parkinson Disease

Article	Year
Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease. ACS chemical neuroscience, 2017, 07-19, Volume: 8, Issue:7 Topics: Administration, Oral; Animals; Antiparkinson Agents; Benzothiazoles; Benzoxazoles; Corpus Striatum; Dopaminergic Neurons; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase	2017
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. Neuropharmacology, 2010, Volume: 58, Issue:1 Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cocaine; Corpus Striatum; Disease Models, Animal; Docosahexaenoic Acids; Dopamine; Dopamine Uptake Inhibitors; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Female; Iodine Isotopes; Levodopa; Macaca fascicularis; Naltrexone; Neuropeptides; Ovariectomy; Parkinsonian Disorders; Piperidines; Protein Precursors; RNA, Messenger; Sulfonamides; Tachykinins; Thiazoles; Time Factors	2010
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Apr-16, Volume: 34, Issue:3 Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Ergolines; Female; Glycogen Synthase Kinase 3; Levodopa; Macaca fascicularis; Oncogene Protein v-akt; Parkinsonian Disorders; Phosphorylation; Piperidines; Serine; Signal Transduction; Statistics as Topic	2010
An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:8 Topics: Animals; Apomorphine; Benzoxazoles; Callithrix; Dopamine Agonists; Female; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Dopamine D3; Serotonin 5-HT1 Receptor Agonists; Sulpiride	2010
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:1 Topics: Animals; Antiparkinson Agents; Benserazide; Benzoxazoles; Corpus Striatum; Dopamine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enkephalins; Female; Gene Expression; Levodopa; Macaca fascicularis; Parkinsonian Disorders; Piperidines; Protein Precursors; Receptors, N-Methyl-D-Aspartate; RNA, Messenger	2006
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:2 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Benzoxazoles; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Convulsants; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Flunitrazepam; GABA Modulators; Isotopes; Levodopa; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Piperidines; Protein Binding; Radiography; Receptors, GABA; Substantia Nigra	2008